Relationship of tumor grade to other pathologic features and to treatment outcome of patients with early stage breast carcinoma treated with breast‐conserving therapy
Asa J. Nixon(Dana-Farber Brigham Cancer Center), James L. Connolly(Beth Israel Deaconess Medical Center), Abram Recht(Beth Israel Deaconess Medical Center), Irene Gage(Johns Hopkins University), Rebecca Gelman(Dana-Farber Cancer Institute), Bruce A. Bornstein(Harvard University), Barbara Silver(Harvard University), Jay R. Harris(Harvard University), Stella Hetelekidis(Dana-Farber Brigham Cancer Center), Stuart J. Schnitt(Brigham and Women's Hospital)
Cited by 9
Related Papers
Molecular Definition of Breast Tumor Heterogeneity
|Cancer Cell|2007|1.4k
Molecular characterization of the tumor microenvironment in breast cancer
|Cancer Cell|2004|1.3k
Revision of the American Joint Committee on Cancer Staging System for Breast Cancer
|Journal of Clinical Oncology|2002|1.2k
Prognostic Factors in Breast Cancer
|Archives of Pathology & Laboratory Medicine|2000|1.1k
The 2019 World Health Organization classification of tumours of the breast
|Histopathology|2020|1.1k